TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11563405

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) at maximally tolerated doses administered orally prior to and continuing for 48 hours following surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM)
Number of subjects: 75
Study: 7862366

Group type: EXPERIMENTAL
Intervention: $5.00 gift certificate
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Gift certificate and a chance to win a $100 raffle
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control group (no incentives)
Number of subjects: 205
Study: 2036944

Group type: EXPERIMENTAL
Intervention: Cognitive training (45 min sessions on 9 days over 15 days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nonspecific attention (control group)
Number of subjects: 14
Study: 7076881

Group type: EXPERIMENTAL
Intervention: Family support intervention and small group sessions
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nonintervention groups
Number of subjects: 200
Study: 31400513

Group type: EXPERIMENTAL
Intervention: Mobile health intervention including behavior change goals, daily text messages with feedback, web-based weight gain graphs, health coaching, and a Facebook support group.
Number of subjects: 262

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 262
Study: 29160101

Group type: EXPERIMENTAL
Intervention: Peripheral nerve block (7.5 mg/mL ropivacaine)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (spinal anesthesia only)
Number of subjects: 57
Study: 27077987

Group type: EXPERIMENTAL
Intervention: IPASS intervention
Number of subjects: 185

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 185
Study: 24990880

Group type: EXPERIMENTAL
Intervention: Quilizumab (humanized monoclonal antibody targeting M1 prime epitope)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quilizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22728756

Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg once daily for those ≥13 years or weight‐based dosing for children 1‐12 years)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 477
Study: 19959338

Group type: EXPERIMENTAL
Intervention: Risperidone 6 mg/day plus mirtazapine 30 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Risperidone 6 mg/day plus placebo
Number of subjects: 40
Study: 18070637

Group type: EXPERIMENTAL
Intervention: Balanced injection (steroid, lidocaine, bupivacaine, and bicarbonate, neutral pH)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Standard injection (steroid, lidocaine, and bupivacaine alone, acidic pH)
Number of subjects: 125
Study: 16140697

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including alcohol-based hand sanitizer and hand-hygiene education
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group receiving only materials promoting good nutrition
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Higher sanitizer usage within intervention group
Number of subjects: 292
Study: 12118873

Group type: EXPERIMENTAL
Intervention: Self-selected typing pace
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fast typing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relative pace of typing
Number of subjects: 0
Study: 10480502

Group type: EXPERIMENTAL
Intervention: Rapid HbA1c results
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Conventional HbA1c results
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1138
Study: 8730527

Group type: EXPERIMENTAL
Intervention: Dietary-fat screening instrument
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Food Habits Questionnaire (FHQ)
Number of subjects: 0
Study: 1908569

Group type: EXPERIMENTAL
Intervention: Solcotrans Plus
Number of subjects: 96

Group type: COMPARATOR
Intervention: Stryker‐CBC ConstaVAC
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 96
Study: 6353278

Group type: EXPERIMENTAL
Intervention: Heparin (intravenous, given for 2 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no heparin)
Number of subjects: 26
Study: 30499237

Group type: EXPERIMENTAL
Intervention: Dapagliflozin plus Saxagliptin (DAPA + SAXA)
Number of subjects: 461

Group type: COMPARATOR
Intervention: Sitagliptin (SITA)
Number of subjects: 461
Study: 29071409

Group type: EXPERIMENTAL
Intervention: Posterior-anterior stabilization
Number of subjects: 21

Group type: COMPARATOR
Intervention: Posterior-only stabilization
Number of subjects: 21
Study: 27809831

Group type: EXPERIMENTAL
Intervention: Tailored brief intervention (BI) incorporating motivational interviewing (MI) and personalized feedback.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored BI with modifications to 'Substance Use Risk' cards and 'Pros and Cons of Substance Use/Reasons to Quit or Cut Down'.
Number of subjects: 0
Study: 25052972

Group type: EXPERIMENTAL
Intervention: 4 mg submucosal dexamethasone injection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 100
Study: 22381303

Group type: EXPERIMENTAL
Intervention: PEG hydrogel (n = 120)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (n = 117)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: PEG hydrogel
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 237
Study: 20222106

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneous 6 monthly)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg oral weekly)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 247
Study: 16959304

Group type: EXPERIMENTAL
Intervention: Nadroparine 2850 units aXa/0.3 ml every 24 h during and 6 weeks after treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no nadroparine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Study group without nadroparine
Number of subjects: 0
Study: 16335023

Group type: COMPARATOR
Intervention: Increasing the intake of cereals (especially breakfast cereals)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Increasing the intake of greens and vegetables
Number of subjects: 67
Study: 12010240

Group type: EXPERIMENTAL
Intervention: Desmopressin treatment
Number of subjects: 120
Study: 11472702

Group type: EXPERIMENTAL
Intervention: Heparin Infusion Prior to Stenting
Number of subjects: 179
Study: 9745993

Group type: EXPERIMENTAL
Intervention: Step test protocol with cycle ergometer (3 steps, 25 Watt each for 6 min)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Step test protocol with cycle ergometer
Number of subjects: 89
Study: 8200332

Group type: EXPERIMENTAL
Intervention: Aludrox plus orange juice
Number of subjects: 15

Group type: COMPARATOR
Intervention: Aludrox alone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aludrox plus milk
Number of subjects: 15
Study: 2494620

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 199

Group type: COMPARATOR
Intervention: No antibiotic (Control)
Number of subjects: 199
Study: 4554660

Group type: EXPERIMENTAL
Intervention: Nitrazepam
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 464448

Group type: COMPARATOR
Intervention: UVB phototherapy
Number of subjects: 38
Study: 31466932

Group type: EXPERIMENTAL
Intervention: Triple-headed toothbrush
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional manual toothbrush
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between triple-headed toothbrush and conventional manual toothbrush
Number of subjects: 60
Study: 29850827

Group type: EXPERIMENTAL
Intervention: Multimedia online educational intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Text-only online educational intervention
Number of subjects: 111
Study: 26748347

Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acid (PUFA) treatment (docosahexaenoic acid (DHA) and eicosapentaenoic acid) (Omacor/Lovaza, 4 g/day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 24760977

Group type: EXPERIMENTAL
Intervention: Fed-Ghrelin
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Fasted-Saline
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fed-Saline
Number of subjects: 21
Study: 22685950

Group type: EXPERIMENTAL
Intervention: Higher parental dental functional health literacy (FHL)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Errors in completing the questionnaire
Number of subjects: 101
Study: 20811761

Group type: EXPERIMENTAL
Intervention: Dual component fibrin mesh (DCFM) (Tachosil, Nycomed, Marlow, UK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polypropylene mesh (PPM) (Prolene, Ethicon, Bracknell, UK)
Number of subjects: 0
Study: 17671229

Group type: EXPERIMENTAL
Intervention: Subtype B, E, and D immunoglobulin G capture immunoassay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment and further validation of the assay
Number of subjects: 0
Study: 16223393

Group type: EXPERIMENTAL
Intervention: Ropivacaine 10 mg with fentanyl 15 microg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Bupivacaine 10 mg with fentanyl 15 microg
Number of subjects: 34
Study: 11962062

Group type: EXPERIMENTAL
Intervention: Combination of antioxidants (vitamins E, C, beta-carotene) and minerals (zinc with copper)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10234344

Group type: EXPERIMENTAL
Intervention: Elective induction of labour at 41 weeks' gestation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectant management with selective labour induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Labour induction at 41 or more weeks' gestation
Number of subjects: 0
Study: 7612076

Group type: EXPERIMENTAL
Intervention: Dynamic strategy (perimetric measurement procedure with variable luminance-step sizes)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dynamic strategy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional strategy (4- to 2-dB strategy with fixed step sizes)
Number of subjects: 40
Study: 1913041

Group type: EXPERIMENTAL
Intervention: Air aspiration after double-contrast knee arthrography
Number of subjects: 0

Group type: COMPARATOR
Intervention: No air aspiration after double-contrast knee arthrography
Number of subjects: 0
Study: 7016567

Group type: EXPERIMENTAL
Intervention: Dipyridamole alone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dipyridamole in combination with fenoterol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30461207

Group type: EXPERIMENTAL
Intervention: Amifostine (200 mg/m2 IV)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (normal saline IV)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 28867766

Group type: EXPERIMENTAL
Intervention: High protein meals (30%)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal protein meals (15%)
Number of subjects: 21
Study: 26908625

Group type: EXPERIMENTAL
Intervention: SLC39A8 SNP (rs13107325)
Number of subjects: 18624

Group type: EXPERIMENTAL
Intervention: NPPB variant
Number of subjects: 18624

Group type: EXPERIMENTAL
Intervention: POC1B/GALNT4 SNP (rs11105306)
Number of subjects: 18624
Study: 24400077

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion during normoglycemia (PG: 4.5 mM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline infusion during normoglycemia (PG: 4.5 mM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion during hypoglycemia (PG: 3.0 mM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline infusion during hypoglycemia (PG: 3.0 mM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 18
Study: 22914601

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 19168537

Group type: EXPERIMENTAL
Intervention: Ultrasound guided corticosteroid and lidocaine injection in the subacromial bursa
Number of subjects: 106

Group type: COMPARATOR
Intervention: Corticosteroid and lidocaine injection in the gluteal region
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Ultrasound guided corticosteroid injection
Number of subjects: 106
Study: 17148569

Group type: EXPERIMENTAL
Intervention: rosiglitazone (8 mg/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: metformin (2 g/d)
Number of subjects: 20
Study: 16311459

Group type: EXPERIMENTAL
Intervention: Finometer
Number of subjects: 19

Group type: COMPARATOR
Intervention: Finapres
Number of subjects: 19
Study: 12239758

Group type: EXPERIMENTAL
Intervention: Cephalic vein cut-down (CCD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Percutaneous subclavian vein puncture (PSP)
Number of subjects: 50
Study: 10191748

Group type: EXPERIMENTAL
Intervention: Vancomycin prophylaxis in patients with large blood loss (greater than 2 L)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Vancomycin prophylaxis in patients with small blood loss (less than 2 L)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Preoperative 1.5 gram-dose of vancomycin for patients weighing more than 90 kg
Number of subjects: 13
Study: 7577153

Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vitamin K+D supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (matched controls)
Number of subjects: 20
Study: 2186854

Group type: EXPERIMENTAL
Intervention: Bestatin (30 mg daily after evacuation)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 44
Study: 345341

Group type: EXPERIMENTAL
Intervention: 0.25 mg glucagon
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1 mg glucagon
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 2 mg glucagon
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29788532

Group type: EXPERIMENTAL
Intervention: Epidural magnesium sulphate (50 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 80
Study: 26718373

Group type: EXPERIMENTAL
Intervention: Compound topical anesthetic (CTA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Needle injection of local anesthetic
Number of subjects: 24
Study: 25342618

Group type: EXPERIMENTAL
Intervention: x-linked retinitis pigmentosa (xlRP)
Number of subjects: 59

Group type: COMPARATOR
Intervention: autosomal dominant retinitis pigmentosa (adRP)
Number of subjects: 59
Study: 22678100

Group type: EXPERIMENTAL
Intervention: Distal venous arterialization (DVA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Antiaggregation therapy
Number of subjects: 60
Study: 20966605

Group type: EXPERIMENTAL
Intervention: AAD plus enalapril
Number of subjects: 344

Group type: COMPARATOR
Intervention: AAD alone
Number of subjects: 344
Study: 18387222

Group type: EXPERIMENTAL
Intervention: Levocetirizine (LCTZ), 5 mg
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Montelukast (MLKT), 10 mg
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 16146574

Group type: EXPERIMENTAL
Intervention: Allergen challenge
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Pollen season exposure
Number of subjects: 69

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 69
Study: 11841418

Group type: EXPERIMENTAL
Intervention: In vitro purged PBSCs
Number of subjects: 60

Group type: COMPARATOR
Intervention: Unmanipulated PBSCs
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 60
Study: 10077045

Group type: EXPERIMENTAL
Intervention: Erythromycin (1 g i.v. per day for 10 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Erythromycin (2 g i.v. per day for 10 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Erythromycin (1 g oral per day for 1.5 to 8 months)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Erythromycin (discontinuation after 1.5 to 8 months)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy volunteers (no erythromycin)
Number of subjects: 34

Group type: COMPARATOR
Intervention: WS patients with >3 years follow-up (no erythromycin)
Number of subjects: 34
Study: 7561633

Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms in 1 ml saline) injected as an i.v. bolus
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hexarelin (100 micrograms in 1 ml saline) injected as an i.v. bolus
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hexarelin (100 micrograms in 1 ml saline) plus GHRH (100 micrograms in 1 ml saline) injected as an i.v. bolus
Number of subjects: 13
Study: 2185569

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol acetate (600 mg)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo (600 mg)
Number of subjects: 105
Study: 36111

Group type: EXPERIMENTAL
Intervention: fominoben
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: pethidine/promethazine
Number of subjects: 36
Study: 31455459

Group type: EXPERIMENTAL
Intervention: Clinical significance criterion (CSC) endorsement
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Subthreshold depression symptoms
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 411
Study: 31028846

Group type: EXPERIMENTAL
Intervention: tRNS (transcranial random noise stimulation) over the left M1 for 10 min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 16
Study: 28177133

Group type: EXPERIMENTAL
Intervention: SRP + dietary supplementation of low-dose omega-3 PUFAs (6.25 mg eicosapentaenoic acid and 19.19 mg docosahexaenoic acid)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SRP + dietary supplementation of low-dose omega-3 PUFAs
Number of subjects: 30

Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 30
Study: 25148566

Group type: EXPERIMENTAL
Intervention: Take Charge of Your Life drug prevention program
Number of subjects: 0
Study: 23887001

Group type: EXPERIMENTAL
Intervention: Traditional problem solving with feedback (unworked example)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Expert demonstration followed by problem solving with feedback (worked example)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Faculty physicians
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Resident physicians
Number of subjects: 120
Study: 21772204

Group type: EXPERIMENTAL
Intervention: Auricular cartilage graft
Number of subjects: 20

Group type: COMPARATOR
Intervention: Absorbable polyacid copolymer
Number of subjects: 20
Study: 19197383

Group type: EXPERIMENTAL
Intervention: 7.5 microg dose of MF59-adjuvanted H5N1 vaccine
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: 15 microg dose of MF59-adjuvanted H5N1 vaccine
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Both formulations of MF59-adjuvanted H5N1 vaccine
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: H5N1/turkey/Turkey/05 strain
Number of subjects: 486
Study: 16861375

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg/day)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 403
Study: 12751274

Group type: EXPERIMENTAL
Intervention: 25 mg M100240 via short intravenous infusion
Number of subjects: 13

Group type: COMPARATOR
Intervention: Oral immediate-release tablet administration
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oral Enterion capsule delivery to the proximal small bowel
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oral immediate-release formulation of M100240
Number of subjects: 13
Study: 11083625

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (400 mg t.i.d. for at least 72 h followed by 750 mg b.i.d. orally)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Ceftazidime (2 g t.i.d. intravenously) plus Amikacin (500 mg b.i.d. intravenously)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 246

Group type: COMPARATOR
Intervention: Ceftazidime plus Amikacin
Number of subjects: 246
Study: 9070558

Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 7845951

Group type: EXPERIMENTAL
Intervention: Various interventions from four multicenter randomized clinical trials for diabetic retinopathy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No specific intervention mentioned
Number of subjects: 0
Study: 2854609

Group type: EXPERIMENTAL
Intervention: Sublingual prazepam 20 mg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Oral prazepam 20 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: N-desmethyl-diazepam (metabolite)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Comparison of area under the curve, maximum concentrations, and times to detect significant levels
Number of subjects: 5
Study: 29577974

Group type: EXPERIMENTAL
Intervention: Repetitions to failure group (RFG, n=17)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Repetitions not to failure group (NFG, n=20)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Equalized volume group (ENFG, n=15)
Number of subjects: 52
Study: 25671801

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 24365106

Group type: EXPERIMENTAL
Intervention: Long term practitioners (LTP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short term meditators (STM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls (non-meditators)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meditators (LTP and STM combined)
Number of subjects: 0
Study: 20398849

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Preoperative radiotherapy alone
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Postoperative therapy with concurrent chemoradiotherapy plus fluoropyrimidine-based chemotherapy
Number of subjects: 33